Effects of recombinant murine (rm) interleukin-12 and rm interferon-γ in mice infected with Bordetella pertussis

Journal of Infectious Diseases

Volumn 174, Issue 4, 1996, Pages 786-789

  Torre, Donato ^a   Speranza, Filippo ^b   Pugliese, Agostino ^b   Perversi, Lorenza ^b   Marone, Piero ^b   Ferrario, Giulio ^b  

^a OSPEDALE DI CIRCOLO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM COLONY; BORDETELLA PERTUSSIS; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; INHALATIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG INFECTION; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL;

EID: 0029840596     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.4.786     Document Type: Article

References (34)

1. Pittman M. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. Rev Infect Dis 1979; 1:401-12.
2. Weiss AA, Hewlett EL. Virulence factors of Bordetella pertussis. Annu Rev Microbiol 1986;40:33-41.
3. Ewanowich CA, Melton AR, Weiss AA, Sherburne RK, Peppier MS. Invasion of HeLa 299 cells by virulent Bordetella pertussis. Infect Immun 1989;57:2698-704.
4. Bromberg K, Tannis G, Steiner P. Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect Immun 1991;59:4715-9.
5. Saukkonen K, Cabellos C, Burroughs M, Prasad S, Tuomanen E. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J Exp Med 1991;173:1143-9.
6. Mills KHG, Barnard A, Watkins J, Redhead K. Cell-mediated immunity to Bordetella pertussis: role of Thl cells in bacterial clearance in a murine respiratory infection model. Infect Immun 1993;61:399-410.
7. Petersen JW, Ibsen PH, Haslov K, Heron I. Proliferate responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobronchial lymph nodes and spleens of mice aerosol infected with Bordetella pertussis. Infect Immun 1992;60:4563-70.
8. Muller I, Garcia-Sanz JA, Titus R, Behin R, Louis J. Analysis of the cellular parameters of the immune response contributing to resistance of mice to infection with the intracellular parasite, Leishmania major. Immunol Rev 1989;112:95-113.
9. Kratz SS, Kurlander RJ. Characterization of the pattern of inflammatory cell influx and cytokine production during the murine host response to Listeria monocytogenes. J Immunol 1988;141:598-606.
10. Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of IFN gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983;158:670-89.
11. Hill HR. Modulation of host defenses with interferon-γ in pediatrics. J Infect Dis 1993;167:(suppl 1):S23-8.
12. D'Andrea A, Rengaraju M, Valiante NM, et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992;176:1387-98.
13. Chehimi J, Starr SE, Frank I, et al. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 1992;175:789-96.
14. Chan SH, Kobayashi M, Santoli D, Perussia B, Trinchieri G. Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/IL-12): role of transcription and mRNA stability in the synergistic interaction between NKSF anf IL-2. J Immunol 1992;148:92-8.
15. Chan SH, Perussia B, Gupta JW, et al. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991;173:869-79.
16. Manetti R, Parronchi P, Giudizi MG, et al. Natural killer cell stimulatory factor (interleukin-12 [IL-12]) induces T helper type 1 (Thl)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-204.
17. Murray HW, Hariprashad J. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J Exp Med 1995;181:387-91.
18. Khan IA, Matsuura T, Kasper LH. Interleukin 12 enhances murine survival against acute toxoplasmosis. Infect Immun 1994;62:1639-42.
19. Tripp CS, Gately MK, Hakimi J, Ling P, Unanue ER. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-γ. J Immunol 1994;152:1883-7.
20. Clemons KV, Brummer E, Stevens DA. Cytokine treatment of central nervous system infection: efficacy of interleukin 12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob Agents Chemother 1994;38:460-4.
21. Torre D, Pugliese A, Speranza F, et al. Interferon-γ levels in serum and bronchoalveolar lavage fluid of mice infected with Bordetella pertussis. J Infect Dis 1993;167:762-5.
22. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokines activities and secreted proteins. J Immunol 1986;136: 2348-54.
23. Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994;263:235-8.
24. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor α are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993;90: 3725-9.
25. Hsieh CS, Macantonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of Thl CD4 T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-9.
26. Kobayashi M, Fritz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170:827-34.
27. Farrar MA, Schreiber RD. The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 1993;11:571-611.
28. Black CM, Catterall JR, Remington JS. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-γ. J Immunol 1987; 138:491-5.
29. Kemmerich B, Rossing TH, Pennington JE. Comparative oxidative microbicidal activity of human blood monocytes and alveolar macrophages and activation by recombinant gamma interferon. Am Rev Respir Dis 1987;136:266-70.
30. Nash TW, Libby DM, Horwitz MA. IFN-γ-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. J Immunol 1988;140:3978-81.
31. Mody CH, Tyler CL, Sitrin RG, Jackson C, Toews GB. Interferon-γ activates rat alveolar macrophages for anticryptococcal activity. Am J Respir Cell Molec Biol 1991;5:19-26.
32. Torre D, Ferrario G, Bonetta G, Perversi L, Tambini R, Speranza F. Effects of recombinant human gamma interferon on intracellular survival of Bordetella pertussis in human phagocytic cells. FEMS Immunol Med Microbiol 1994;9:183-8.
33. Debs RJ, Fuchs HJ, Philip R, et al. Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats. J Immunol 1988;140:3482-8.
34. Jaffe HA, Buhl R, Mastrangeli A, et al. Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-γ to the human lung. J Clin Invest 1991;88: 297-302.